Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Food Res Int ; 126: 108604, 2019 12.
Article in English | MEDLINE | ID: mdl-31732021

ABSTRACT

This work aimed to develop a novel colorimetric indicator film for monitoring of food freshness based on gelatin/polyvinyl alcohol matrix incorporated with anthocyanin extracts from mulberry. The color of anthocyanin extracts solutions obviously changed from bright red to dark green in the pH range of 2.0-11.0. FTIR spectra and isothermal titration calorimetry showed that the anthocyanin extracts were successfully combined with gelatin/polyvinyl alcohol matrix by hydrogen binding and electrostatic interaction, which enhanced the stability of anthocyanin. The scanning electric microscopy showed that the compatibility between polyvinyl alcohol and gelatin were improved owing to the addition of anthocyanin extracts. With the anthocyanin extracts addition from 0 to 45 mg/100 mL mixed solution, the tensile strength decreased from 30.80 to 21.01 MPa and the elongation at break increased from 589.22% to 905.86%. The color response of film in buffer solution of different pH were in accordance with anthocyanin extracts solutions, and its color changes were clearly visible with naked eye. Finally, the film was evaluated by a test on monitoring fish spoilage, which presented visible color changes due to volatile nitrogenous compounds formed over time. These results showed that this developed film could be used as an effective method for the monitoring of food freshness.


Subject(s)
Anthocyanins/chemistry , Food Packaging/instrumentation , Indicators and Reagents/chemistry , Morus/chemistry , Polyvinyl Alcohol/chemistry , Seafood , Animals , Colorimetry , Fishes , Food Storage/instrumentation , Gelatin/chemistry , Hydrogen Bonding , Hydrogen-Ion Concentration , Microscopy, Electron, Scanning , Plant Extracts/chemistry , Spectroscopy, Fourier Transform Infrared , Static Electricity
2.
Stem Cells Transl Med ; 5(9): 1162-70, 2016 09.
Article in English | MEDLINE | ID: mdl-27381991

ABSTRACT

UNLABELLED: : Adipose-derived mesenchymal stem cells (AD-MSCs) have been shown to ameliorate hyperglycemia in diabetic animals and individuals. However, little is known about whether AD-MSCs affect lipid metabolism. Here we have demonstrated for the first time that AD-MSC infusion can significantly suppress the increase in body weight and remarkably improve dyslipidemia in db/db obese mice and diet-induced obesity mice. Induction of white fat tissue "browning" and activation of adenosine monophosphate-activated protein kinase and its downstream hormone-sensitive lipase in adipose tissue contribute to the antiobesity and lipid-lowering effects. Thus, AD-MSC infusion holds great therapeutic potential for dyslipidemia and associated cardiovascular diseases. SIGNIFICANCE: Mesenchymal stem cells (MSCs) are considered one of the most promising types of stem cells for translational application because of their rich tissue sources, multilineage differentiation capacity, and easy amplification in vitro and unique immunobiological properties. This study demonstrated that adipose-derived MSCs (AD-MSCs) infusion can significantly suppress the increase in body weight and remarkably improve dyslipidemia in obese mice. Induction of white fat tissue "browning" and activation of adenosine monophosphate-activated protein kinase and its downstream hormone-sensitive lipase in adipose tissue were demonstrated to contribute to the antiobesity and lipid-lowering effects. Thus, AD-MSC infusion holds great therapeutic potential for dyslipidemia.


Subject(s)
Adipose Tissue/cytology , Dyslipidemias/metabolism , Mesenchymal Stem Cell Transplantation , AMP-Activated Protein Kinases/metabolism , Animals , Blood Glucose , Blotting, Western , Disease Models, Animal , Immunohistochemistry , Lipids/blood , Male , Mesenchymal Stem Cells , Mice , Mice, Inbred C57BL , Mice, Obese , Real-Time Polymerase Chain Reaction , Sterol Esterase/metabolism
3.
Cytotherapy ; 18(1): 53-64, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26719199

ABSTRACT

BACKGROUND AIMS: Mesenchymal stromal cells (MSCs) possess the ability to repair brain injuries. Additionally, nimodipine is a neuroprotective agent that increases cerebral blood flow and may help with the homing of MSCs to the injury site. Here we investigate the effectiveness of a combined human umbilical cord-derived MSCs and nimodipine therapy in radiation-induced brain injury (RIBI). METHODS: Female mice received whole brain irradiation (WBI) and were treated with saline, nimodipine, hUC-MSCs, or hUC-MSCs combined with nimodipine. Body weight was measured weekly. An open field test for locomotor activity and a step-down avoidance test for learning and memory function were conducted at week 4 and week 12 post-WBI. The histological damage was evaluated by hematoxylin and eosin staining and glial fibrillary acidic protein immunohistochemistry. Quantitative polymerase chain reaction and Western blotting were used to detect apoptosis-related mediators (p53, Bax and Bcl-2). RESULTS: In mice receiving the hUC-MSCs or the combined treatment, their body weight recovered, their locomotor and cognitive ability improved, and the percentage of necrotic neurons and astrocytes was reduced. The combined therapy was significantly (P < 0.05) more effective than hUC-MSCs alone; these mice showed decreased expression of pro-apoptotic indicators (p53, Bax) and increased expression of an anti-apoptotic indicator (Bcl-2), which may protect brain cells. CONCLUSIONS: We demonstrated that hUC-MSCs therapy helps recover body weight loss and behavior dysfunction in a mice model of RIBI. Moreover, the effectiveness of the combined hUC-MSCs and nimodipine therapy is due to apoptosis inhibition and enhancing homing of MSCs to the injured brain.


Subject(s)
Apoptosis/drug effects , Brain Injuries/therapy , Mesenchymal Stem Cells/cytology , Neuroprotective Agents/metabolism , Nimodipine/pharmacology , Radiation Injuries/therapy , Umbilical Cord/cytology , Animals , Astrocytes/drug effects , Astrocytes/pathology , Body Weight/drug effects , Brain Injuries/metabolism , Cell Count , Cell Differentiation/drug effects , Cell Lineage/drug effects , Cell Survival/drug effects , Combined Modality Therapy , Disease Models, Animal , Exploratory Behavior/drug effects , Female , Humans , Male , Memory/drug effects , Mesenchymal Stem Cell Transplantation , Mesenchymal Stem Cells/metabolism , Mice, Inbred C57BL , Motor Activity/drug effects , Neurons/drug effects , Neurons/pathology , Radiation Injuries/pathology , beta-Globins/genetics , beta-Globins/metabolism
4.
Cell Mol Immunol ; 13(3): 369-78, 2016 05.
Article in English | MEDLINE | ID: mdl-25942600

ABSTRACT

Mesenchymal stem/stromal cells (MSCs) possess some characteristics of immune cells, including a pro-inflammatory phenotype, an immunosuppressive phenotype, antibacterial properties and the expression of Toll-like receptor proteins. Here we show that, similar to immune cells, MSCs retain information from danger signals or environmental stimuli for a period of time. When treated with the pro-inflammatory factors lipopolysaccharide (LPS) or tumor necrosis factor-α (TNF-α), MSCs display increased expression of IL-6, IL-8 and MCP-1. Following re-plating and several rounds of cell division in the absence of stimulating factors, the expression of IL-6, IL-8 and MCP-1 remained higher than in untreated cells for over 7 days. A spike in cytokine secretion occurred when cells were exposed to a second round of stimulation. We primed MSCs with LPS and LPS-primed MSCs had better therapeutic efficacy at promoting skin flap survival in a diabetic rat model than did unprimed MSCs. Finally, we found that several microRNAs, including miR146a, miR150 and miR155, along with the modification of DNA by 5-hydroxymethylcytosine (5hmC), mediate the MSC response to LPS and TNF-α stimulation. Collectively, our data suggest that MSCs have a short-term memory of environmental signals, which may impact their therapeutic potential.


Subject(s)
Immunologic Memory , Mesenchymal Stem Cell Transplantation , Mesenchymal Stem Cells/metabolism , Signal Transduction , 5-Methylcytosine/analogs & derivatives , 5-Methylcytosine/metabolism , Adipose Tissue/cytology , Animals , Cell Differentiation/drug effects , Cell Proliferation/drug effects , Cell Shape/drug effects , Chemokine CCL2/metabolism , DNA Methylation/drug effects , Diabetes Mellitus, Experimental/pathology , Enzyme-Linked Immunosorbent Assay , Immunologic Memory/drug effects , Immunophenotyping , Interleukin-6/metabolism , Interleukin-8/metabolism , Lipopolysaccharides/pharmacology , Male , Mesenchymal Stem Cells/cytology , Mesenchymal Stem Cells/drug effects , MicroRNAs/genetics , MicroRNAs/metabolism , Rats, Wistar , Real-Time Polymerase Chain Reaction , Signal Transduction/drug effects , Surgical Flaps/physiology , Tissue Survival/drug effects , Tumor Necrosis Factor-alpha/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...